
Fe3 Medical Inc. designs and commercializes transdermal patches for iron deficiency anemia treatment.
Fe3 Medical Inc. was founded with the mission to innovate drug delivery systems, specifically focusing on addressing iron deficiency anemia through advanced technology. The company's core product is a transdermal delivery patch designed to provide a non-invasive and efficient method for iron supplementation. By targeting the pharmaceutical industry, Fe3 Medical aims to offer a practical solution to a widespread health issue, enhancing patient compliance and overall treatment outcomes.
Notable figures associated with Fe3 Medical include experts in pharmaceutical development and medical technology innovation. The company has garnered attention from investors interested in cutting-edge healthcare solutions. Key achievements include the successful design and commercialization of their transdermal patch, which has shown promise in clinical settings. Fe3 Medical's impact lies in its potential to revolutionize the treatment of iron deficiency anemia, offering a more convenient and effective alternative to traditional oral supplements.

Keylika
keylika.com

Sidero Bioscience
siderobio.com
Thyritope Biosciences

Early Bird Medical
earlybirdmed.com

Femasys
femasys.com

Micron Biomedical

Solution Medical

Ferric Contrast

Invicta Medical

Infused Medical Technology

Prometheon Pharma

Inari Medical
inarimedical.com

VitaScan
vitascan.me

Micro Medical Solutions

Efemoral Medical
Companies similar to Fe3 Medical include Keylika, Sidero Bioscience, Thyritope Biosciences and Early Bird Medical.
Fe3 Medical was founded in 2008.
Fe3 Medical's headquarters is located in San Jose, CA, US.
Fe3 Medical's most recent funding round was for $3.5M (USD) in August 2016.
As of Aug 8, 2016, Fe3 Medical has raised a total of $21.3M (USD).